09/16/2026
The Schinazi Lab, along with the Burwitz Lab at Oregon Health & Science University (OHSU) and Aligos Therapeutics, Inc., a clinical-stage biotechnology company, has received a $2.5 million Concept Stage award from BARDA's SMART Antiviral Prize.
Led by principal investigator Dr. Raymond Schinazi, the collaborative team is working to develop broad-spectrum, small-molecule antiviral therapies targeting the Flaviviridae virus family, which affects millions globally each year.
Read more about this exciting milestone in Emory News! 👇
Emory University’s Schinazi Lab has recently been awarded a SMART Prize for the Concept Stage. Partners on this prize include the Burwitz Lab at Oregon Health & Science University and Aligos Therapeutics, Inc.